Document is current
Any future updates will be listed below
-
Authors
Jacot, William
Cayrefourcq, Laure
Dunyach-Remy, Catherine
Jarlier, Marta
Lossaint, Gerald
D’Hondt, Véronique
Pastre, Théo
Garima, Françoise
Massemin, Blandine
Guiu, Séverine
Dupuy, Anne Marie Gorce
Cristol, Jean-Paul
Lavigne, Jean-Philippe
Alix-Panabières, Catherine
-
Funding
Funding for this research was provided by:
FEDER (No. 25014115)
CANCER-ID program (No. 115749)
Centre Hospitalier Régional Universitaire de Montpellier (Recherche Tremplin’ initiative)
- License Information
-
More Information
Article History
Received: 25 June 2026
Accepted: 6 July 2026
First Online: 11 August 2026
Declarations
Ethics approval and consent to participate: This study has been approved by the French National Agency for Drug and Health Products Safety (ANSM) on April 3rd 2015 under the reference 150221B-12, and by the Ile de France IV Ethics Committee on April 1 st 2015 under the reference 29–15. All patients gave their written informed consent.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
